semaglutide food interactions List When Taking and What to Avoid What Not to Eat on

As obesity continues to place a major burden on health systems, medications that can improve health outcomes while simultaneously decreasing the cost of healthcare may influence future healthcare policy and population health

The FLOW clinical trial (ClinicalTrials.gov NCT03819153) is currently evaluating the effect of injective semaglutide on the progression of renal damage in subjects with chronic kidney disease

Low non-HDL cholesterol levels are typically not a concern and may indicate a reduced risk of cardiovascular disease

This should be discussed with a prescriber or pharmacist

The risk of hypoglycaemia is typically minor